The company plans to offer a test that analyzes genome-wide sequencing data using a machine learning engine to detect and characterize early cancers.
The deal provides Clinical Genomics with a "cornerstone piece" as it readies its blood-based test for colorectal cancer recurrence for commercialization in the US later this year.
The company plans to launch its first bladder cancer test in the second half of the year, and is in the early stages of validating a third test for prostate cancer.
In Genome Biology this week: methylation changes in aging, single-cell RNA sequencing of renal cell carcinoma tumor, and more.
In Genome Biology this week: computational approach to tease apart clonal tumor lineages, cell type-specific lncRNA expression in developing human neocortex, and more.
Researchers have found nearly 175 genomic loci that are differentially methylated in people with schizophrenia.
Through a meta-analysis, a consortium linked maternal smoking during pregnancy to differential methylation sites in infant genomes.
Yale researchers used a targeted ChIP-seq method on the PacBio RSII to identify a new epigenetic mark in mice stem cells that may play a role in gene silencing.
The company will use the funds to advance commercialization of its blood test for post-surgical monitoring of colorectal cancer occurrence.
In PNAS this week: methylation patterns trace cell-free DNA to tissue of origin, cell surface proteome of Ewing sarcoma tumor cells, and more.
Researchers describe a way to share data while keeping it secure, Agence France Presse reports.
In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.
India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.
A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.